Table 4 Characteristics of patients who were registered on the PaTz-register and who were also discussed in 10 PaTz-groups in a one-year follow-up period
Patients who were registered | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|  | Total N = 583 | 1 N = 75 | 2 N = 107 | 3 N = 122 | 4 N = 48 | 5 N = 40 | 6 N = 45 | 7 N = 29 | 8 N = 39 | 9 N = 36 | 10 N = 42 |
Age, years (mean, range) | 74 (34–101) | 77 (39–98) | 78 (47–99) | 78 (34–101) | 66 (36–89) | 74 (55–97) | 71 (41–97) | 70 (43–88) | 71 (37–95) | 72 (58–90) | 67 (40–95) |
Sex (% male) | 50 | 49 | 50 | 49 | 55 | 43 | 51 | 66 | 40 | 59 | 51 |
Diagnosis | |||||||||||
 Cancer % | 65 | 36 | 63 | 57 | 81 | 78 | 89 | 100 | 72 | 58 | 71 |
 Organ failure % | 17 | 19 | 19 | 30 | 13 | 23 | 7 | 0 | 10 | 6 | 12 |
 Frailty / dementia % | 10 | 28 | 13 | 12 | 2 | 0 | 4 | 0 | 3 | 0 | 5 |
Other % | 10 | 28 | 7 | 8 | 0 | 3 | 4 | 0 | 5 | 28 | 7 |
Patients who were also discussed | |||||||||||
|  | Total N = 243 | 1 N = 39 | 2 N = 13 | 3 N = 21 | 4 N = 23 | 5 N = 39 | 6 N = 22 | 7 N = 21 | 8 N = 27 | 9 N = 26 | 10 N = 12 |
Age, years (mean, range) | 73 (37–98) | 78 (39–98) | 79 (63–94) | 74 (37–95) | 67 (46–81) | 75 (55–97) | 71 (41–92) | 73 (58–88) | 70 (37–90) | 75 (58–90) | 62 (49–92) |
Sex (% male) | 54 | 49 | 54 | 62 | 73 | 41 | 50 | 71 | 54 | 52 | 55 |
Diagnosis | |||||||||||
 Cancer % | 70 | 39 | 69 | 76 | 87 | 77 | 86 | 100 | 59 | 58 | 83 |
 Organ failure % | 13 | 18 | 23 | 14 | 13 | 21 | 5 | 0 | 15 | 8 | 0 |
 Frailty / dementia % | 6 | 26 | 8 | 5 | 0 | 0 | 0 | 0 | 4 | 0 | 8 |
 Other % | 12 | 28 | 15 | 5 | 0 | 3 | 9 | 0 | 7 | 35 | 0 |